PT  - JOURNAL ARTICLE
AU  - Schöffski, Patrick
AU  - Tan, Daniel S W
AU  - Martín, Miguel
AU  - Ochoa-de-Olza, María
AU  - Sarantopoulos, John
AU  - Carvajal, Richard D
AU  - Kyi, Chrisann
AU  - Esaki, Taito
AU  - Prawira, Amy
AU  - Akerley, Wallace
AU  - De Braud, Filippo
AU  - Hui, Rina
AU  - Zhang, Tian
AU  - Soo, Ross A
AU  - Maur, Michela
AU  - Weickhardt, Andrew
AU  - Krauss, Jürgen
AU  - Deschler-Baier, Barbara
AU  - Lau, Allen
AU  - Samant, Tanay S
AU  - Longmire, Tyler
AU  - Chowdhury, Niladri Roy
AU  - Sabatos-Peyton, Catherine A
AU  - Patel, Nidhi
AU  - Ramesh, Radha
AU  - Hu, Tiancen
AU  - Carion, Ana
AU  - Gusenleitner, Daniel
AU  - Yerramilli-Rao, Padmaja
AU  - Askoxylakis, Vasileios
AU  - Kwak, Eunice L
AU  - Hong, David S
TI  - Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
AID  - 10.1136/jitc-2021-003776
DP  - 2022 Feb 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e003776
VI  - 10
IP  - 2
4099  - http://jitc.bmj.com/content/10/2/e003776.short
4100  - http://jitc.bmj.com/content/10/2/e003776.full
SO  - J Immunother Cancer2022 Feb 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.